F. Xavier Kowalski represents issuers, sponsors and investment banks in initial public offerings, high-yield financings, equity-linked financings, and other domestic and international capital markets transactions. He also counsels clients in general corporate and securities law matters. His practice includes a broad range of cross-border transactions across a number of targeted industries, including health care, media and entertainment, and technology. He also brings significant experience in private equity and leveraged finance transactions. 

Representations

  • Albertsons’ $800-million IPO
  • Performance Food Group Company’s $317-million IPO
  • Nielsen’s $1.9-billion IPO
  • Catalent’s $1.0-billion IPO
  • Initial purchasers in financing for Stone Point Capital’s acquisition of Alliant
  • Spin-off of SAIC from Leidos

Publications

“SEC Reporting Companies Granted Further Extension of Filing Relief Due to COVID-19,” SRZ Alert, March 27, 2020

Speaking Engagements

“SPACs,” SRZ 30th Annual Private Investment Funds Seminar, January 2021

“FAQ Secondary Tender Offers,” SRZ 29th Annual Private Investment Funds Seminar, New York, January 2020

“Secondary Transactions: Tender Offers, Side Pocket Clearing and Residual Assets,” SRZ 28th Annual Private Investment Funds Seminar, New York, January 2019

SRZ Distressed Investing Hot Topics  Trading Next Generation Products, New York, June 2017

Prior Experience

  • Simpson Thacher & Bartlett, 2006-2017